DLHCX
Price
$20.90
Change
-$0.03 (-0.14%)
Updated
Jul 25 closing price
Net Assets
647.12M
FSPHX
Price
$25.87
Change
+$0.16 (+0.62%)
Updated
Jul 25 closing price
Net Assets
5.92B
Interact to see
Advertisement

DLHCX vs FSPHX

Header iconDLHCX vs FSPHX Comparison
Open Charts DLHCX vs FSPHXBanner chart's image
Macquarie Healthcare C
Price$20.90
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets647.12M
Fidelity Select Health Care
Price$25.87
Change+$0.16 (+0.62%)
VolumeN/A
Net Assets5.92B
DLHCX vs FSPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLHCX vs. FSPHX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.92B vs. DLHCX (647M). FSPHX pays higher dividends than DLHCX: FSPHX (0.02) vs DLHCX (0.00). DLHCX was incepted earlier than FSPHX: DLHCX (16 years) vs FSPHX (44 years). DLHCX (2.00) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLHCX (5.00). FSPHX has a lower initial minimum investment than DLHCX: FSPHX (0) vs DLHCX (1000). FSPHX annual gain was more profitable for investors over the last year : -13.29 vs. DLHCX (-19.49). FSPHX return over 5 years is better than : -15.91 vs. DLHCX (-19.12).
DLHCXFSPHXDLHCX / FSPHX
Total Expense Ratio1.960.63311%
Annual Report Gross Expense Ratio2.000.63317%
Fund Existence16 years44 years-
Gain YTD-0.381-5.0648%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets647M5.92B11%
Annual Yield % from dividends0.000.02-
Returns for 1 year-19.49-13.29147%
Returns for 3 years-12.95-3.88333%
Returns for 5 years-19.12-15.91120%
Returns for 10 years1.656.2427%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLPG32.651.80
+5.83%
Galapagos NV
ALV117.351.50
+1.29%
Autoliv
CMPX3.180.02
+0.63%
Compass Therapeutics
SLRX0.75N/A
-0.17%
Salarius Pharmaceuticals Inc.
PYXS1.25-0.09
-6.72%
Pyxis Oncology